Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.90   -0.026 (2.81%)  0.86 - 0.95  550,200

Overview

 
Avg Volume (4 weeks):2,657,750
4 Weeks Range:0.84 - 8.00
4 Weeks Price Volatility (%):
0.84%
52 Weeks Range:0.10 - 8.00
52 Weeks Price Volatility (%):
10.13%
Average Price Target: 3.00
Price Target Upside/Downside: +2.10

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


 

3245  4476  792  197 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HMNY 0.02+0.001 
 SPY 280.45+0.05 
 AMD 27.30-0.88 
 CZR 10.20+1.11 
 GE 12.19+0.09 
 XLF 27.02+0.27 
 BAC 28.90+0.37 
 EEM 40.36-0.50 
 VXX 32.47+0.49 
 QQQ 177.29+0.07 
Partners & Brokers